Tirzepatide (Mounjaro, Zepbound) is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management
Most telehealth providers require a BMI of 27 or higher with at least one weight-related health condition, or a BMI of 30 or higher regardless of comorbidities
Some natural active ingredients (e.g., chitosan, hyaluronic acid) not only possess inherent anti-inflammatory and mucosal repair activities but can also serve as efficient delivery carriers to enhance the retention and bioavailability of 5-ASA at inflammatory sites, achieving dual functions of therapy and delivery ( 4 Discussion The combination of 5-ASA with TCM and its bioactive constituents represents an important advance in the therapeutic strategy for ulcerative colitis
Valued at approximately USD 1.2 billion in 2023, industry analysts project a compound annual growth rate (CAGR) of 8.5% from 2024 to 2030
Because GLP-1s stop working when not taken, weight loss maintenance is another category of interest
Increased Energy and Endurance: L-Carnitine transports fatty acids to the mitochondria, where they are converted into energy